The Relationship Between Lymphocyte Recovery, Specific Antibody Level and 2019-Ncov Reversion in Convalescent Patients with COVID-19

翟荣荣,苏虹,姚宗烽,杨权,权惠,田婷婷,黄新明,王保龙

DOI: https://doi.org/10.3760/cma.j.cn114452-20200328-00319

2020-01-01

Abstract:Objective:A retrospective analysis was performed on COVID-19 patients to explore the correlations among lymphocytes, virus-specific antibodies (immunoglobulin M and immunoglobulin G) and the 2019 novel coronavirus (2019-nCoV) reversion.Methods:A total of 69 patients diagnosed with COVID-19 in Lu′an Hospital affiliated to Anhui Medical University from January 20, 2020 to March 3, 2020 were recruited. Throat swab specimens were collected and tested by real-time polymerase chain reaction for 2019-nCoV in 14 days post-discharge. Seven patients (mean age 36.3±5.8 years) experienced virus reversion were selected as reversion group, while the 62 remaining cases (mean age 44.4±11.5 years) were assigned to the recovery group. The parametric/non-parametric tests were applied to discriminate clinical features and total lymphocyte count (on admission and on discharge) between the two groups. One-way ANOVA was used to evaluate the impact of lymphocyte on different stages of disease course in virus-reversion group. Specific antibody levels were compared by using nonparametric tests.Results:Virus reversion occurred at a rate of 10% (7/69). The reversion period took a median 8 days. There was no significant difference between the two groups in length of hospital stay, age, gender, history of smoking and/or drinking,coinfection and underlying disease ( P>0.05). Total lymphocyte count in recovery group was significantly higher on discharge than on admission [(1.29±0.33)×10 9/L, (1.14±0.41)×10 9/L, respectively; t=-2.097, P=0.038], while there were no significant change in reactivation group [(1.48±0.51)×10 9/L, (1.54±0.74)×10 9/L, respectively; t=0.206, P=0.840]. Total lymphocyte count was significantly higher in reversion group than in recover group both on admission and at discharge ( t=-2.552, P=0.016; t=-2.023, P=0.048). No apparent change was found in total lymphocyte count during the different stage of disease in reversion group [(1.54±0.74)×10 9/L, (1.48±0.51)×10 9/L, (1.64±0.33)×10 9/L, (1.57±0.31)×10 9/L, respectively; F=0.127, P=0.943]. There was no significant difference in levels of IgM [2.65(1.98,3.45), 2.95(1.31,4.51)], and IgG [4.61(4.01, 5.78), 4.56(2.50, 5.45)between the two groups ( Z=-0.295, P=0.768; Z=-0.319, P=0.075), respectively. Conclusion:The immune systems of COVID-19 patients at high risk for virus reversion may respond lightly to the 2019-nCOV infection, leading to a prolonged virus presence after discharge.